Cowealth Medical China Co.Ltd. (603122) — Working Capital to Net Assets Ratio
Cowealth Medical China Co.Ltd. (603122) has a Working Capital to Net Assets ratio of 71.7% as of March 2026. Working capital of CN¥749.61 Million (current assets of CN¥1.12 Billion minus current liabilities of CN¥366.26 Million) is measured against net assets of CN¥1.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 603122 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cowealth Medical China Co.Ltd. Working Capital to Net Assets (2019–2025)
This chart shows how Cowealth Medical China Co.Ltd.'s Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 71.7%, reflecting working capital of CN¥749.61 Million against net assets of CN¥1.05 Billion CNY. See operational self-sufficiency of Cowealth Medical China Co.Ltd. to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Cowealth Medical China Co.Ltd. (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cowealth Medical China Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Cowealth Medical China Co.Ltd. market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 71.5% | CN¥757.41 Million | CN¥1.06 Billion | CN¥1.12 Billion | CN¥366.88 Million | ▼ -11.3 pp |
| 2024 | 82.8% | CN¥972.28 Million | CN¥1.17 Billion | CN¥1.29 Billion | CN¥318.70 Million | ▼ -0.1 pp |
| 2023 | 82.9% | CN¥969.07 Million | CN¥1.17 Billion | CN¥1.25 Billion | CN¥285.73 Million | ▼ -6.2 pp |
| 2022 | 89.1% | CN¥1.05 Billion | CN¥1.18 Billion | CN¥1.41 Billion | CN¥361.55 Million | ▲ +5.1 pp |
| 2021 | 84.0% | CN¥668.24 Million | CN¥795.77 Million | CN¥969.85 Million | CN¥301.61 Million | ▲ +1.2 pp |
| 2020 | 82.8% | CN¥593.43 Million | CN¥717.02 Million | CN¥966.91 Million | CN¥373.48 Million | ▼ -0.2 pp |
| 2019 | 83.0% | CN¥655.22 Million | CN¥789.41 Million | CN¥985.43 Million | CN¥330.21 Million | — |